Theraclion SA - Balance Sheet (Quarterly)

Theraclion SA
US ˙ OTCPK ˙ FR0010120402

Balance Sheet (Quarterly)

Theraclion SA Balance Sheet shows account balances for the company at points in time. Balance Sheet data includes Assets, Current Assets, Fixed Assets, Property, Plant and Equipment (PPE), Inventory, Intangibles, Liabilities, Current Liabilities, Debt, Capital Lease Obligations, Common Stock, Retained Earnings, Treasury Stock, and Shareholders Equity.

All numbers are times 1,000,000.00 except per share units.

2020
09-30
2020
12-31
2021
09-30
2021
12-31
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
Cash 2 2 2 2 2 2 9 9 8 8 6 6 4 4
Change (%) 0.00 6.38 0.00 1.11 0.00 264.75 0.00 -13.91 0.00 -24.53 0.00 -29.28 0.00
Assets Current 7 7 8 8 9 9 16 16 16 16 12 12 8 8
Change (%) 0.00 13.57 0.00 17.73 0.00 75.04 0.00 -1.53 0.00 -27.37 0.00 -29.31 0.00
Assets 11 11 12 12 14 14 21 21 19 19 14 14 11 11
Change (%) 0.00 12.18 0.00 17.86 0.00 49.70 0.00 -10.58 0.00 -24.01 0.00 -19.15 0.00
Liabilities 14 14 13 13 13 13 14 14 13 13 12 12 11 11
Change (%) 0.00 -4.95 0.00 2.26 0.00 6.88 0.00 -9.10 0.00 -11.05 0.00 -0.97 0.00
Equity -3 -3 -1 -1 1 1 7 7 6 6 3 3 -0 -0
Change (%) -0.00 -60.71 -0.00 -142.81 0.00 1,102.67 0.00 -13.82 0.00 -53.89 0.00 -100.00 -0.00
Liabilities And Stock Equity 11 11 12 12 14 14 21 21 19 19 14 14 11 11
Change (%) 0.00 12.18 0.00 17.86 0.00 49.70 0.00 -10.58 0.00 -24.01 0.00 -19.15 0.00

Source: Capital IQ

Other Listings
DE:941
FR:ALTHE €0.70
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista